Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial

Chad Tang, Alexander D. Sherry, Cara Haymaker, Tharakeswara Bathala, Suyu Liu, Bryan Fellman, Lorenzo Cohen, Ana Aparicio, Amado J. Zurita, Alexandre Reuben, Enrica Marmonti, Stephen G. Chun, Jay P. Reddy, Amol Ghia, Sean McGuire, Eleni Efstathiou, Jennifer Wang, Jianbo Wang, Patrick Pilie, Craig KovitzWeiliang Du, Samantha J. Simiele, Rachit Kumar, Yerko Borghero, Zheng Shi, Brian Chapin, Daniel Gomez, Ignacio Wistuba, Paul G. Corn

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences